Citadel Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Buy |
152,460
+58,463
| +62% | +$158K | ﹤0.01% | 4275 |
|
|
2025
Q1 | $319K | Sell |
93,997
-95,873
| -50% | -$325K | ﹤0.01% | 4405 |
|
|
2024
Q4 | $782K | Buy |
+189,870
| New | +$782K | ﹤0.01% | 3502 |
|
|
2024
Q2 | – | Sell |
-15,982
| Closed | -$32.9K | – | 6130 |
|
|
2024
Q1 | $32.9K | Sell |
15,982
-7,226
| -31% | -$14.9K | ﹤0.01% | 5425 |
|
|
2023
Q4 | $41.8K | Buy |
+23,208
| New | +$41.8K | ﹤0.01% | 5191 |
|
|
2023
Q3 | – | Sell |
-7,740
| Closed | -$10.6K | – | 6019 |
|
|
2023
Q2 | $10.6K | Sell |
7,740
-23,070
| -75% | -$31.6K | ﹤0.01% | 5372 |
|
|
2023
Q1 | $72.7K | Buy |
+30,810
| New | +$72.7K | ﹤0.01% | 5033 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6084 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6225 |
|
|
2022
Q1 | – | Sell |
-10,174
| Closed | -$45K | – | 6532 |
|
|
2021
Q4 | $45K | Buy |
+10,174
| New | +$45K | ﹤0.01% | 6185 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6534 |
|
|
2021
Q2 | – | Sell |
-25,062
| Closed | -$268K | – | 6547 |
|
|
2021
Q1 | $268K | Buy |
+25,062
| New | +$268K | ﹤0.01% | 5146 |
|
|
2020
Q3 | – | Sell |
-3,016
| Closed | -$25K | – | 4798 |
|
|
2020
Q2 | $25K | Buy |
+3,016
| New | +$25K | ﹤0.01% | 4463 |
|
|
2019
Q4 | – | Sell |
-3,365
| Closed | -$38K | – | 4734 |
|
|
2019
Q3 | $38K | Buy |
3,365
+1,162
| +53% | +$13.1K | ﹤0.01% | 4404 |
|
|
2019
Q2 | $40K | Buy |
+2,203
| New | +$40K | ﹤0.01% | 4395 |
|